These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5003583)

  • 1. Improved microbiological assay for cytosine arabinoside (NSC-63878).
    Hanka LJ; Kuentzel SL; Neil GL
    Cancer Chemother Rep; 1970 Dec; 54(6):393-7. PubMed ID: 5003583
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of deamination of 14C-cytosine arabinoside (NSC-63878): a useful biologic assay for tetrahydrouridine (NSC-112907).
    Furner RL; Mellett LB
    Cancer Chemother Rep; 1975; 59(4):717-20. PubMed ID: 809135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiologic assay for cytosine arabinoside (NSC-63878): the use of a mutant of streptococcus faecium var. durans resistant to methotrexate (NSC-740) and 6-mercaptopurine (NSC-755).
    Mehta BM; Meyers MB; Hutchison DJ
    Cancer Chemother Rep; 1975; 59(3):515-22. PubMed ID: 1203881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiological assay for cytosine arabinoside (NSC-63878) in biologic materials containing other antitumor or antibacterial drugs.
    Hanka LJ
    Cancer Chemother Rep; 1971 Dec; 55(5):557-60. PubMed ID: 5003620
    [No Abstract]   [Full Text] [Related]  

  • 5. A microbiological assay for cyclocytidine--disposition studies in mice.
    Neil GL; Kuentzel SL; Berger AE
    Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):561-72. PubMed ID: 4633769
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytosine arabinoside sensitivity in actinobolin-resistant Streptococcus faecalis: the basis of a utilitarian microbiological assay.
    Pittillo RF; Hunt DE
    Proc Soc Exp Biol Med; 1967 Feb; 124(2):636-40. PubMed ID: 4960087
    [No Abstract]   [Full Text] [Related]  

  • 7. Tetrahydrouridine: Physiologic disposition and effect upon deamination of cytosine arabinoside in man.
    Kreis W; Woodcock TM; Gordon CS; Krakoff IH
    Cancer Treat Rep; 1977 Oct; 61(7):1347-53. PubMed ID: 589600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma half-life of cytosine arabinoside (NSC-63878) in patients treated for acute myeloblastic leukemia.
    Baguley BC; Falkenhaug EM
    Cancer Chemother Rep; 1971 Jun; 55(3):291-8. PubMed ID: 5286668
    [No Abstract]   [Full Text] [Related]  

  • 9. A mechanism for the hydrolytic deamination of cytosine arabinoside in aqueous buffer.
    Notari RE
    J Pharm Sci; 1967 Jul; 56(7):804-9. PubMed ID: 6034820
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacologic studies of tritiated cytosine arabinoside (NSC-63878) in children.
    Finklestein JZ; Scher J; Karon M
    Cancer Chemother Rep; 1970 Feb; 54(1):35-9. PubMed ID: 5538163
    [No Abstract]   [Full Text] [Related]  

  • 11. 5-mercaptodeoxyuridine--its enzymatic synthesis and mode of action in microbiological systems.
    Baranski K; Bardos TJ; Bloch A; Kalman TI
    Biochem Pharmacol; 1969 Feb; 18(2):347-58. PubMed ID: 4976026
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.
    Avramis VI; Powell W
    Cancer Invest; 1987; 5(4):293-9. PubMed ID: 3664332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of folylpolyglutamate hydrolase using pteroyl-labeled substrates and selective short-term bacterial uptake for product determination.
    Elsenhans B; Selhub J; Rosenberg IH
    Methods Enzymol; 1980; 66():663-6. PubMed ID: 6768966
    [No Abstract]   [Full Text] [Related]  

  • 14. [Microbiological methods of pharmacokinetic research on chemotherapeutic (antibacterial and antitumor) preparations].
    Smolianskaia AZ; Spitsyna TA
    Antibiot Med Biotekhnol; 1987 Feb; 32(2):151-5. PubMed ID: 3105435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive radioimmunoassay for cytarabine and uracil arabinoside in plasma.
    Sato T; Morozumi M; Kodama K; Kuninaka A; Yoshino H
    Cancer Treat Rep; 1984 Nov; 68(11):1357-66. PubMed ID: 6498853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The methylenetetrahydrofolate-mediated biosynthesis of ribothymidine in the transfer-RNA of Streptococcus faecalis: incorporation of hydrogen from solvent into the methyl moiety.
    Delk AS; Nagle DP; Rabinowitz JC; Straub KM
    Biochem Biophys Res Commun; 1979 Jan; 86(2):244-51. PubMed ID: 106850
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of the response of patients with acute nonlymphocytic leukemia to cytosine arabinoside (NSC-63878) therapy.
    Burns CP; Armentrout SA; Stjernholm RL
    Cancer Chemother Rep; 1972 Aug; 56(4):527-34. PubMed ID: 4507687
    [No Abstract]   [Full Text] [Related]  

  • 18. Disposition of arabinosylcytosine (NSC-63878) and 6-THIOGUANINE (NSC-752) in solid L1210 leukemia tumor-bearing mice.
    Pittillo RF; Woolley C
    Cancer Chemother Rep; 1973; 57(3):275-89. PubMed ID: 4201593
    [No Abstract]   [Full Text] [Related]  

  • 19. Sparing action of uridine on the activity of arabinosylcytosine with normal and leukemic mice.
    Saslaw LD; Grindey GB; Kline I; Waravdekar VS
    Cancer Res; 1968 Jan; 28(1):11-20. PubMed ID: 5635365
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancement by tetrahydrouridine of 1-beta-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice.
    Neil GL; Moxley TE; Manak RC
    Cancer Res; 1970 Aug; 30(8):2166-72. PubMed ID: 4990003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.